Tevogen Bio Holdings Inc. share price logo

Tevogen Bio Holdings Inc.

NASDAQ: TVGNW

$0.03

(+2.97%)

as on

Tevogen Bio Holdings Inc. Stock Performance

as on May 13, 2026 at 5:28 am IST

  • $0.03
    $0.03
  • 52 Week's Low

    52 Week's High

    $0.03
    $0.08
    downward going graph

    15.67%

    Downside

    166.67%

    Upside

    downward going graph

Tevogen Bio Holdings Inc. share price movements today

Previous Close
$0.03
Open
$0.03
Volume
2.5M
Day's Low - High
$0.03 - $0.03
52 Week Low - High
$0.03 - $0.08

Tevogen Bio Holdings Inc. Historical Returns

1 Month Return
+ 9.06 %
3 Month Return
-20.33 %
1 Year Return
-29.79 %
3 Year Return
0 %
5 Year Return
0 %

Tevogen Bio Holdings Inc. Stock Fundamentals & Key Indicators

Check Tevogen Bio Holdings Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

0.00%

Tevogen Bio Holdings Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Tevogen Bio Holdings Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
NA$-NANA0.00%
BUY$22.5B292.63%NA-144.44%
BUY$39.4B113.59%74.1312.55%
BUY$109.1B104.61%25.5135.51%
BUY$74.9B40.55%17.4529.65%

Stock Returns calculator for Tevogen Bio Holdings Inc. Stock including INR - Dollar returns

The Tevogen Bio Holdings Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Tevogen Bio Holdings Inc. investment value today

Current value as on today

₹67,587

Returns

-₹32,413

(-32.41%)

Returns from Tevogen Bio Holdings Inc. Stock

-₹40,000 (-40%)

Dollar Impact

₹7,587 (+7.59%)

Indian Investors' Interest in Tevogen Bio Holdings Inc. Stock

Search interest for Tevogen Bio Holdings Inc. Stock has decreased by -56% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-56% versus previous 30 day period

Tevogen Bio Holdings Inc. Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
-
-
-
-
0
-
-
-
Gross Profit
0
0
0
0
0
-
0
0
0
0
Operating Income
-2
-2
-29
-8
-6
-9
-10
-5
-5
-4
EBITDA
-3
-3
11
-9
-5
-
-10
-5
-5
-4
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
-
0
0
0
0
0
0
0
0
Income Before Tax
-3
-3
11
-9
-5
-9
-10
-5
-5
-4
Income Tax Expense
0
0
48
-3
-5
-
0
-
-
-
Net Income
-3
-3
11
-6
-5
-9
-10
-5
-5
-4
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-2614.08%
0.00%
0.00%
0.00%

Tevogen Bio Holdings Inc. Annual Profit & Loss

All numbers in Millions USD

Jun 2022
Jun 2023
Jun 2024
Jun 2025
Total Revenue
-
-
-
-
Gross Profit
-
-
0
0
Operating Income
-4
0
-8
-53
EBITDA
-14
4
-58
-13
Interest Expense
0
-
0
0
Depreciation
0
0
0
0
Income Before Tax
-15
4
-60
-13
Income Tax Expense
-9
0
0
-
Net Income
-15
4
-60
-10
Net Profit Margin
0.00%
0.00%
0.00%
0.00%

Tevogen Bio Holdings Inc. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-3
11
-9
-5
-9
-10
-5
-5
-4
Operating Cash Flow
-1
-2
-2
-3
-3
-3
-3
-3
-2
Investing Cash Flow
9
-
-
-
-
-
-
-
0
Financing Cash Flow
0
2
2
5
2
4
1
4
1
Change in Cash
0
0
0
1
-1
0
-1
0
0

Tevogen Bio Holdings Inc. Annual Cash Flow

All numbers in Millions USD

Jun 2023
Jun 2024
Jun 2025
Net Income
-22
-60
-13
Operating Cash Flow
-8
-8
-11
Investing Cash Flow
0
0
-
Financing Cash Flow
7
3
12
Change in Cash
-1
-4
0

Insights on Tevogen Bio Holdings Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Insmed Incorporated has given 152.5% return, outperforming this stock by 164.9%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, TVGNW stock has moved down by -14.1%

About Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment of ambulatory high-risk adult COVID-19 patients; and in Phase 1 clinical trial to treat acute SARS-CoV-2 patients with B-cell cancer immune suppression, and other B cell immune suppressed acute SARS-CoV-2 patients with a B cell cancer indication, as well as Long COVID prevention and treatment. It is also developing TVGN 920 which is in preclinical trial for treating cervical cancer; TVGN 960 which is in preclinical trial for treating oropharyngeal cancer; TVGN 601 which is in preclinical trial for treating multiple sclerosis; TVGN 930 which is in preclinical trial for treating Epstein-Barr virus associated lymphomas; and TVGN 116 a product candidate targeted at hepatitis B and is in preclinical trial. Tevogen Bio Holdings Inc. was formerly known as Tevogen Bio Inc. and changed its name to Tevogen Bio Holdings Inc. in February 2024. The company was founded in 2020 and is headquartered in Warren, New Jersey.
OrganisationTevogen Bio Holdings Inc.
Headquarters15 Independence Boulevard, Warren, NJ, United States, 07059
IndustryMiscellaneous
CEODr. Ryan H. Saadi M.D., M.P.H.
E-voting on sharesClick here to vote

Key Management of Tevogen Bio Holdings Inc.

Name

Title

Mr. Mittul Mehta

Chief Information Officer & Head of Tevogen.ai

Mr. Tapan V. Shah

Head of Investor Relations & Corporate Development

Mr. Sadiq Khan M.B.A.

Chief Commercial Officer & Interim Head of Tevogen Generics

Mr. David E. Banko CPA

Global Head of Government Affairs & Patient Access

Dr. Ryan H. Saadi M.D., M.P.H.

Co-Founder, CEO & Chairperson

Mr. Kirti Desai CPA

Chief Financial Officer

Dr. Neal Flomenberg M.D.

Chief Scientific Officer and Global R&D Lead

Mr. Stephen Chen M.B.A.

Chief Technical Officer

FAQs

What is Tevogen Bio Holdings Inc. share price today?

Tevogen Bio Holdings Inc. share price today is $0.03 as on at the close of the market. Tevogen Bio Holdings Inc. share today touched a day high of $0.03 and a low of $0.03.

What is the 52 week high and 52 week low for Tevogen Bio Holdings Inc. share?

Tevogen Bio Holdings Inc. share touched a 52 week high of $0.08 on and a 52 week low of $0.03 on . Tevogen Bio Holdings Inc. stock price today i.e. is closed at $0.03,which is 62.50% down from its 52 week high and 18.58% up from its 52 week low.

How to invest in Tevogen Bio Holdings Inc. Stock (TVGNW) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Tevogen Bio Holdings Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tevogen Bio Holdings Inc. Shares that will get you 50.0000 shares as per Tevogen Bio Holdings Inc. share price of $0.03 per share as on May 12, 2026 at 11:58 pm IST.

What is the minimum amount required to buy Tevogen Bio Holdings Inc. Stock (TVGNW) from India?

Indian investors can start investing in Tevogen Bio Holdings Inc. (TVGNW) shares with as little as ₹95.618 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.18 in Tevogen Bio Holdings Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Tevogen Bio Holdings Inc. share’s latest price of $0.03 as on May 12, 2026 at 11:58 pm IST, you will get 333.3333 shares of Tevogen Bio Holdings Inc.. Learn more about fractional shares .